Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.

March 16, 2018March 16, 2018

ASTRO Guideline Recommends Larger Doses of Radiation, Fewer Sessions

News

A new guideline for treating breast cancer patients with whole breast irradiation recommends that most patients receive an accelerated treatment, known as hypofractioned therapy, instead of the conventional one. ... Read more

November 15, 2017November 15, 2017

European Commission Approves Faslodex-Ibrance Combo for Advanced Breast Cancer

News

The European Commission (EC) has extended the approval of AstraZeneca‘s breast cancer therapy Faslodex (fulvestrant) to be used in combination with Ibrance (palbociclib) for advanced breast cancers. The combination can now be ... Read more

November 2, 2017November 2, 2017

‘Rollover’ Trial to Test Breast Cancer Vaccine, BriaVax, in Combo with Yervoy or Keytruda

News

A “rollover” clinical trial of BriaVax — used in combination with Keytruda (pembrolizumab) or Yervoy (ipilimumab) — will soon begin to treat women with advanced breast cancer who did not ... Read more

September 29, 2017September 29, 2017

Nerlynx Delays Invasive Disease in Breast Cancer Patients Treated with Herceptin, ExteNET Trial Shows

News

Researchers found an increase in invasive disease-free survival (iDFS) in patients with early-stage breast cancer treated with Puma Biotechnology’s Nerlynx (neratinib) after initial treatment with Herceptin (trastuzumab). Quality of life ... Read more

May 1, 2017

Tumor ‘Paint’ Aids Breast Cancer Surgeons and Well-Tolerated by Patients, Study Reports

News

BLZ-100 (tozuleristide) was found to be well-tolerated by patients and to make breast cancer tumors more easily seen during surgery in a Phase 1 clinical trial, Blaze Bioscience announced. BLZ-100 ... Read more